Search Results - Skrabek, Pamela J.

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma

    Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma by Tennese, Alysa, Skrabek, Pamela J., Nasr, Michel R., Sekiguchi, Debora R., Morales, Carmen, Brown, Theresa C., Weisenburger, Dennis D., Perry, Anamarija M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Versus R-GDP

    Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse La... by Stewart, Douglas A., Shepherd, Lois E., Dudebout, Jill J., Larouche, Jean-François, Chua, Neil, Baetz, Tara, Crump, Michael, Shafey, Mona, Abdel-Samad, Nizar, Robinson, Sue, Fleury, Isabelle, Marcellus, Deborah, Skrabek, Pamela, Kelly, Jesse, Hay, Annette E., Chen, Bingshu, Kuruvilla, John

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Canadian cancer trials group LY .17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐ DICEP ) versus R‐ GDP

    Canadian cancer trials group LY .17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell ly... by Stewart, Douglas A., Kuruvilla, John, Lee, David, Dudebout, Jill J., Chua, Neil, Larouche, Jean‐François, Baetz, Tara, Shafey, Mona, Abdel‐Samad, Nizar, Robinson, Sue, Fleury, Isabelle, Fraser, Graeme, Skrabek, Pamela, Kukreti, Vishal, Kelly, Jesse, Hay, Annette E., Shepherd, Lois E., Chen, Bingshu E., Crump, Michael

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP

    Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lym... by Stewart, Douglas A., Kuruvilla, John, Lee, David, Dudebout, Jill J., Chua, Neil, Larouche, Jean‐François, Baetz, Tara, Shafey, Mona, Abdel‐Samad, Nizar, Robinson, Sue, Fleury, Isabelle, Fraser, Graeme, Skrabek, Pamela, Kukreti, Vishal, Kelly, Jesse, Hay, Annette E., Shepherd, Lois E., Chen, Bingshu E., Crump, Michael

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: